Managing Director, Zydus Lifesciences
Appears in 1 story
Leading Zydus's shift into branded U.S. medicines
Zydus, one of India's largest drugmakers, now owns a U.S. cancer-care drug. On June 16, 2026, it finished buying Assertio Holdings for $23.50 a share in cash, a deal worth about $166 million.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
